Imaging challenges of immunotherapy and targeted therapy in patients with brain metastases: Response, Progression, and Pseudoprogression.

Clicks: 404
ID: 12994
2019
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #4 of 43 articles by views in Neuro-Oncology

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
The advent of immunotherapy using immune checkpoint inhibitors (ICI) and targeted therapy (TT) has dramatically improved the prognosis of various cancer types. Following ICI therapy or TT, either alone (especially ICI) or in combination with radiotherapy, however, imaging findings on anatomical contrast-enhanced MRI can be unpredictable, highly variable, and are often difficult to interpret regarding treatment response and outcome. This review aims at summarizing the imaging challenges related to TT and ICI monotherapy as well as combined with radiotherapy in patients with brain metastases, and to give an overview on advanced imaging techniques which potentially overcome some of these imaging challenges. Currently, major evidence suggests that imaging parameters especially derived from amino acid PET, perfusion-/diffusion-weighted MRI, or MR spectroscopy may provide valuable additional information for the differentiation of treatment-induced changes from brain metastases recurrence and the evaluation of treatment response.
Reference Key
galldiks2019imagingneurooncology Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Galldiks, Norbert;Kocher, Martin;Ceccon, Garry;Werner, Jan-Michael;Brunn, Anna;Deckert, Martina;Pope, Whitney B;Soffietti, Riccardo;Le Rhun, Emilie;Weller, Michael;Tonn, Jörg C;Fink, Gereon R;Langen, Karl-Josef;
Journal Neuro-Oncology
Year 2019
DOI
noz147
URL
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.